PFS
ACAD icon

Prospera Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Prospera Financial Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,642
Closed -$211K – 385
2016
Q3 		$211K Sell
6,642
-540
-8% -$18.3K 0.04% 336
2016
Q2 		$233K Sell
7,182
-1,750
-20% -$58.6K 0.05% 291
2016
Q1 		$250K Buy
8,932
+1,632
+22% +$35.6K 0.06% 251
2015
Q4 		$260K Sell
7,300
-4,800
-40% -$169K 0.06% 222
2015
Q3 		$400K Buy
+12,100
New +$503K 0.1% 142

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Prospera Financial Services's ACAD Position: Q4 2016 in Review

Prospera Financial Services sold out of Acadia Pharmaceuticals (ACAD) in Q4 2016, closing a stake of 6,642 shares — an estimated $211K sold.

Prospera Financial Services first reported a position in ACAD in Q3 2015 and held it in 5 quarters. The position peaked at $400K in Q3 2015. 225 funds tracked by Wall St. Rank hold ACAD as of Q4 2016.

  • Prospera Financial Services reported no remaining Acadia Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Prospera Financial Services sold 6,642 Acadia Pharmaceuticals shares in Q4 2016, an estimated $211K.
  • Prospera Financial Services first reported a position in Acadia Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Prospera Financial Services's Acadia Pharmaceuticals position peaked at $400K in Q3 2015.
  • 225 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2016.

Based on Prospera Financial Services's 13F filing for Q4 2016, filed 11 Jan 2017.